Zobrazeno 1 - 10
of 128
pro vyhledávání: '"Simon, Kung"'
Autor:
Nicolas A. Nuñez, Brandon J. Coombes, Lindsay Melhuish Beaupre, Aysegul Ozerdem, Manuel Gardea Resendez, Francisco Romo-Nava, David J. Bond, Marin Veldic, Balwinder Singh, Katherine M. Moore, Hannah K. Betcher, Simon Kung, Miguel L. Prieto, Manuel Fuentes, Mete Ercis, Alessandro Miola, Jorge A. Sanchez Ruiz, Gregory Jenkins, Anthony Batzler, Jonathan G. Leung, Alfredo Cuellar-Barboza, Susannah J. Tye, Susan L. McElroy, Joanna M. Biernacka, Mark A. Frye
Publikováno v:
Translational Psychiatry, Vol 14, Iss 1, Pp 1-5 (2024)
Abstract There is increasing interest in individualizing treatment selection for more than 25 regulatory approved treatments for major depressive disorder (MDD). Despite an inconclusive efficacy evidence base, antidepressants (ADs) are prescribed for
Externí odkaz:
https://doaj.org/article/30895815cfaa4cdd8a949170cc6615ae
Autor:
Dylan L. Kosaski, PharmD, Kristin C. Cole, Jessica A. Wright, Razan M. El Melik, PharmD, Simon Kung, MD, Wayne T. Nicholson, MD, PharmD, Jonathan G. Leung, PharmD
Publikováno v:
Mental Health Clinician, Vol 13, Iss 6, Pp 303-310 (2023)
Introduction: Although there are studies assessing reasons for antidepressant discontinuation, little is known about the impact of sex differences or cytochrome P450 phenotypes. Our objective is to assess discontinuation rates between males and femal
Externí odkaz:
https://doaj.org/article/f5adae5ad7144ff49dbe80593e6fe2d3
Publikováno v:
Brain Stimulation, Vol 16, Iss 4, Pp 8- (2023)
Externí odkaz:
https://doaj.org/article/0946509f83eb4b5db4ed4700e9a8ae1f
Autor:
Boney Joseph, Nicolas A. Nunez, Simon Kung, Jennifer L. Vande Voort, Vanessa K. Pazdernik, Kathryn M. Schak, Stacey M. Boehm, Brooke Carpenter, Emily K. Johnson, Grigoriy Malyshev, Nathan Smits, Daniel O. Adewunmi, Sarah K. Brown, Balwinder Singh
Publikováno v:
Pharmaceuticals, Vol 16, Iss 11, p 1571 (2023)
In the original publication [...]
Externí odkaz:
https://doaj.org/article/2c096edf7825442aa0bcae4609ae7183
Publikováno v:
Brain Stimulation, Vol 16, Iss 1, Pp 277- (2023)
Externí odkaz:
https://doaj.org/article/4cd444fe1c174f9a8344cd5a864617b7
Autor:
Andrea Collins, B.A., Joseph Cheung, M.D., Paul Croarkin, D.O., Bhanu Prakash Kolla, M.D., Simon Kung, M.D.
Publikováno v:
Brain Stimulation, Vol 15, Iss 5, Pp 1327- (2022)
Externí odkaz:
https://doaj.org/article/49f0d7b9064345c9b345498b2e947f65
Autor:
Boney Joseph, Nicolas A. Nunez, Simon Kung, Jennifer L. Vande Voort, Vanessa K. Pazdernik, Kathryn M. Schak, Stacey M. Boehm, Brooke Carpenter, Emily K. Johnson, Grigoriy Malyshev, Nathan Smits, Daniel O. Adewunmi, Sarah K. Brown, Balwinder Singh
Publikováno v:
Pharmaceuticals, Vol 16, Iss 8, p 1164 (2023)
Intravenous (IV) ketamine and FDA-approved intranasal (IN) esketamine are increasingly used for treatment-resistant depression (TRD). Preliminary studies have suggested a synergistic effect of ketamine and lamotrigine, although the data are inconclus
Externí odkaz:
https://doaj.org/article/41630fded47c432bbbbd045cbc8254ae
Publikováno v:
Psychiatry Research Communications, Vol 2, Iss 2, Pp 100033- (2022)
Background: To study the efficacy of repetitive Transcranial Magnetic Stimulation (rTMS) in Major Depressive Disorder (MDD) including comorbidities of Generalized Anxiety Disorder (GAD), Post-Traumatic Stress Disorder (PTSD), and Borderline Personali
Externí odkaz:
https://doaj.org/article/0b3fae4ae9434260984047530aae0caa
Publikováno v:
Sleep Science and Practice, Vol 5, Iss 1, Pp 1-10 (2021)
Abstract Repetitive transcranial magnetic stimulation (rTMS) is a neuromodulatory technique approved by the US Food and Drug Administration for use in treatment-resistant major depressive disorder. It works by generating localized magnetic fields tha
Externí odkaz:
https://doaj.org/article/8595b29941d748fd957bcb9c8c6b7424
Autor:
Ruth E. Bates, MD, Jonathan G. Leung, PharmD, RPh, Robert J. Morgan, III, MD, Karen M. Fischer, MPH, Kemuel L. Philbrick, MD, Simon Kung, MD
Publikováno v:
Mayo Clinic Proceedings: Innovations, Quality & Outcomes, Vol 4, Iss 5, Pp 542-549 (2020)
Objective: To evaluate the efficacy and safety of a fixed-dose gabapentin taper protocol for alcohol withdrawal in hospitalized patients. Patients and Methods: We retrospectively identified patients admitted to the hospital from January 1, 2016, to A
Externí odkaz:
https://doaj.org/article/76c61b0ffb484cf584fbe142eeafd2cd